<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the research was to show our diagnostic and therapeutic experience with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) in pregnant women </plain></SENT>
<SENT sid="1" pm="."><plain>36 pregnant women suspect on APS were included in the study: 32 with primary antiphospholipd syndrome (PAPS) and 4 with <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> (SAPS) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> pregnant women received low-molecular-weight-<z:chebi fb="5" ids="28304">heparin</z:chebi> (LMWH) and low dose aspirin (LDA) therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Control group represented 26 women with SAPS and previous bad reproductive anamnesis </plain></SENT>
<SENT sid="4" pm="."><plain>Average pregnancy lasted 37.06 +/- 0.707 weeks </plain></SENT>
<SENT sid="5" pm="."><plain>LMWH and LDA therapy was successful in 97.22% </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) was found to be more frequent in PAPS group (71.87%) </plain></SENT>
<SENT sid="7" pm="."><plain>Anticardiolipin antibodies (aCL) were found to be more frequent in SAPS (26.66%) </plain></SENT>
<SENT sid="8" pm="."><plain>For three patients (3.37%), PAPS was diagnosed due to a fact that they had positive antibeta2-glycoproteinl (antibeta-GP1) </plain></SENT>
<SENT sid="9" pm="."><plain>To make APS diagnosis, it is of great importance to search for <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>LMWH and low dose of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> should be the first choice therapy </plain></SENT>
</text></document>